Tacitus Therapeutics Launches in Collaboration with Mount Sinai to Develop Stem Cell Therapies for Life-Threatening Diseases; Tacitus Therapeutics exclusively licenses technology for expansion, differentiation and engineering of hematopoietic stem cells f

Press/Media

Period9 Jan 2020

Media coverage

2

Media coverage